Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Tonix Pharmaceuticals' TONMYA Sales Jump 37% as Insurance Coverage Expands
Tonix Pharmaceuticals Holding Corp. (TNXP) Q3 2026 Earnings Call Transcript
What Tonix Pharmaceuticals (TNXP) Said on Its Q3 Earnings Call
Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights
Tonix Pharmaceuticals to Present at Guggenheim's 3rd Annual Healthcare Innovation Conference
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
A New Fibromyalgia Drug Deal Reaches 21 Million More Medicare Lives. Her Own Plan Could Still Decide What She Pays
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Analyzing Tonix Pharmaceuticals (NASDAQ:TNXP) and WAVE Life Sciences (NASDAQ:WVE)
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
Tonix Pharmaceuticals (NASDAQ:TNXP) and Voyager Therapeutics (NASDAQ:VYGR) Critical Review
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Tonix Pharmaceuticals to Participate in Cantor's 2026 Global Healthcare Conference
Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline
Tonix Pharmaceuticals Q2 Earnings Call Highlights
Tonix Pharmaceuticals Holding Corp. (TNXP) Q2 2026 Earnings Call Transcript